Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Freed

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Dermatologic Surgery and Oncology|September 1, 1989
Aesthetic problems in chemical peelingP M Goldman, M I Freed
The Yale Journal of Biology and Medicine|March 1, 1991
Effects of calcium channel blockers on potassium homeostasisM I Freed, A Rastegar, M J Bia
Journal of Virology|June 1, 1983
Stoichiometry of large T antigen and pp53 in complexes isolated from simian virus 40-transformed rat cellsM I Freed, I Lubin, D T Simmons
Thrombosis and Haemostasis|October 1, 1994
Effect of acetylsalicylic acid on inhibition of ex vivo platelet aggregation and secretion by SKF 107260, a novel GPIIb/IIIa receptor antagonistM I Freed, S Boike, N Zariffa, et al.
The Journal of International Medical Research|September 19, 2002
Pharmacokinetics of rosiglitazone in patients with end-stage renal diseaseK Thompson-Culkin, B Zussman, A K Miller, et al.
The American Journal of Physiology|July 1, 1992
Effects of chronic metabolic acidosis on Na(+)-H+ exchangers in LLC-PK1 renal epithelial cellsP Igarashi, M I Freed, M B Ganz, et al.
European Journal of Clinical Pharmacology|April 17, 1999
Systemic exposure to rosiglitazone is unaltered by foodM I Freed, A Allen, D K Jorkasky, et al.
Journal of Clinical Pharmacology|February 24, 2001
Rosiglitazone does not affect the steady-state pharmacokinetics of digoxinR A Di Cicco, A K Miller, S Patterson, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Rosiglitazone monotherapy is effective in patients with type 2 diabetesH E Lebovitz, J F Dole, R Patwardhan, et al.
Journal of Human Hypertension|February 7, 2003
Rosiglitazone reduces urinary albumin excretion in type II diabetesG Bakris, G Viberti, W M Weston, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Dermatologic Surgery and Oncology|September 1, 1989
Aesthetic problems in chemical peelingP M Goldman, M I Freed
The Yale Journal of Biology and Medicine|March 1, 1991
Effects of calcium channel blockers on potassium homeostasisM I Freed, A Rastegar, M J Bia
Journal of Virology|June 1, 1983
Stoichiometry of large T antigen and pp53 in complexes isolated from simian virus 40-transformed rat cellsM I Freed, I Lubin, D T Simmons
Thrombosis and Haemostasis|October 1, 1994
Effect of acetylsalicylic acid on inhibition of ex vivo platelet aggregation and secretion by SKF 107260, a novel GPIIb/IIIa receptor antagonistM I Freed, S Boike, N Zariffa, et al.
The Journal of International Medical Research|September 19, 2002
Pharmacokinetics of rosiglitazone in patients with end-stage renal diseaseK Thompson-Culkin, B Zussman, A K Miller, et al.
The American Journal of Physiology|July 1, 1992
Effects of chronic metabolic acidosis on Na(+)-H+ exchangers in LLC-PK1 renal epithelial cellsP Igarashi, M I Freed, M B Ganz, et al.
European Journal of Clinical Pharmacology|April 17, 1999
Systemic exposure to rosiglitazone is unaltered by foodM I Freed, A Allen, D K Jorkasky, et al.
Journal of Clinical Pharmacology|February 24, 2001
Rosiglitazone does not affect the steady-state pharmacokinetics of digoxinR A Di Cicco, A K Miller, S Patterson, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Rosiglitazone monotherapy is effective in patients with type 2 diabetesH E Lebovitz, J F Dole, R Patwardhan, et al.
Journal of Human Hypertension|February 7, 2003
Rosiglitazone reduces urinary albumin excretion in type II diabetesG Bakris, G Viberti, W M Weston, et al.
Pageof 3